US 7678890
Compositions and methods of treating disease with FGFR fusion proteins
granted A61KA61K45/06A61P
Quick answer
US patent 7678890 (Compositions and methods of treating disease with FGFR fusion proteins) held by Five Prime Therapeutics, Inc. expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K45/06, A61P, A61P1/02, A61P1/04